Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Cesium carbonate | HCID 10796 | — |
| Reactant | N-bromobutanimide | HCID 67184 | — |
| Reactant | HCID 90037528 | HCID 90037528 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Solvent | Ammonium Chloride | HCID 25517 | — |
| Product | HCID 131736368 | HCID 131736368 | 127% |
Reaction Steps
Cs2CO3 (331 mg, 1.01 mmol, Eq: 2.2) was added was added to a solution of tert-butyl methyl((S)-1-oxo-1-((S)-4-oxo-2′,3′,4,5,5′,6′-hexahydro-3H-spiro[benzo[b][1,4]oxazepine-2,4′-pyran]-3-ylamino)propan-2-yl)carbamate (200 mg, 461 μmol, Eq: 1.00) and DMF (10 mL) and the mixture was cooled to 0° C. and a solution of NBS (82.1 mg, 461 μmol, Eq: 1.00) in 2 mL DMF was added dropwise over 5 min. and the mixture warmed to RT. After 10 h the mixture was diluted with sat. NH4Cl and extracted with EtOAc. The combined extracts were washed with H2O, concentrated and the residue was purified by preparative TLC to give tert-butyl (S)-1-((S)-8-bromo-4-oxo-2′,3′,4,5,5′,6′-hexahydro-3H-spiro[benzo[b][1,4]oxazepine-2,4′-pyran]-3-ylamino)-1-oxopropan-2-yl(methyl)carbamate (300 mg, 98%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09394263B2 |
|---|
| Source dataset | uspto-grants-2016_07 |
|---|
| ORD ID | ord-bd084e355ad3453bb44746f572005c47 |
|---|
| Source note | uspto-grants-2016_07 |
|---|